Bishuang Cai
- Icahn School of Medicine at Mount Sinai · Internal Medicine (NIH department code)
From the FY2024 NIH awards this investigator leads as contact PI. The department is the award's.
FY2024 NIH rank #7,580
- R01 Holder
- Early Career
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 12015184Search this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
FY2026 award categories
- Internal Medicine
NIH Funding · FY2024
Linked Award Amount
$1.6M
Full award amounts, FY2024
Award Records
3
Records listing this PI
Award-Linked Rank
#7,580
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2024 award records by amount
NIH award records listing Bishuang Cai as a PI. Multi-PI records show the full award amount for context.
- 5R01HL167107-02R01Contact PIEHD1-mediated Inflammation and Resolution in AtherosclerosisIcahn School of Medicine at Mount Sinai · Internal Medicine (NIH department code)$689.5Kaward amount
- 5R01DK134610-02R01Contact PIDisturbed Crosstalk between Cholesterol Homeostasis and Inflammation Resolution in NASHIcahn School of Medicine at Mount Sinai · Internal Medicine (NIH department code)$521.8Kaward amount
- 5R35GM147269-03R35Contact PIEfferocytosis meets endocytosisIcahn School of Medicine at Mount Sinai · Internal Medicine (NIH department code)$422.5Kaward amount
Award organization
Organizations that administered FY2024 awards listing Bishuang Cai as a PI.
FY2024 award administered by Icahn School of Medicine at Mount Sinai (NY).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardIcahn School of Medicine at Mount Sinai
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #7580
- 2025$2M Cumulative Funding
- 2025R01 Grant Holder